Digital & Innovation
Digital Acceleration Roundtable Series
Digital & Innovation: Digital transformation in the healthcare industry has been accelerated as a result of the COVID-19 pandemic and it is crucial to drive enhanced patient care, cost-effectiveness, greater stakeholder engagement, and improved drug and medical device development.
In this four part series, digital leaders across the Pharma and MedTech sectors, share their expertise and insights on navigating the fast-changing digital landscape to re-shape customer engagement models and drive innovation in the ‘new normal’.
News & Trends - Pharmaceuticals
Healthcare affordability and accessibility top priority for consumers ahead of Federal Budget
Pharma News: With the Federal Budget set to be delivered in just one week, there is a critical need for […]
MoreNews & Trends - Pharmaceuticals
UCB secures registration of rheumatology drug
Pharma News: UCB Australia has secured Therapeutic Goods Administration (TGA) approval of its therapy for psoriatic arthritis (PsA), non-radiographic axial […]
MoreDigital & Innovation
Targeted funding of digital health technologies key to unlocking $5 billion in savings: New report
Digital & Innovation: Integrating digital technology into healthcare more effectively could alleviate pressures on our healthcare system and lead to […]
MoreNews & Trends - MedTech & Diagnostics
Surgeons welcome ‘significant win’ for patients, amidst clash with health insurers
MedTech & Diagnostics News: The Royal Australasian College of Surgeons (RACS) is heralding a significant triumph for Australian patients following […]
More